List of Implanon drug patents

Implanon is owned by Organon.

Implanon contains Etonogestrel.

Implanon has a total of 4 drug patents out of which 0 drug patents have expired.

Implanon was authorised for market use on 17 July, 2006.

Implanon is available in implant;implantation dosage forms.

Implanon can be used as prevention of pregnancy.

The generics of Implanon are possible to be released after 28 July, 2030.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8888745 ORGANON Applicator for inserting an implant
Aug, 2026

(3 years from now)

US10821277 ORGANON Kit for and method of assembling an applicator for inserting an implant
May, 2027

(4 years from now)

US8722037 ORGANON X-ray visible drug delivery device
Sep, 2027

(4 years from now)

US9757552 ORGANON Applicator for inserting an implant
Jul, 2030

(7 years from now)

Drugs and Companies using ETONOGESTREL ingredient

Market Authorisation Date: 17 July, 2006

Treatment: Prevention of pregnancy

Dosage: IMPLANT;IMPLANTATION

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic